You just read:

Medicenna Reports Promising Efficacy in Phase 2b MDNA55 Clinical Trial at the Society for Neuro-Oncology Annual Meeting

News provided by

Medicenna Therapeutics Corp.

Nov 25, 2019, 07:30 ET